Alpay Azap
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 8
-
- Antibiotic Resistance in Bacteria 8
- Co-authors
- Önder ErgönülErkan KalafatAcar KoçÇağlar UzunFatma Şebnem ErdinçAyşe Willkeİrem Akdemir KalkanH. Karakayalı
- Journals
- International Journal of Antimicrobial Agents (2 papers)American Journal of Infection Control (2 papers)Infectious Diseases and Therapy (2 papers)Scientific Reports (1 paper)International Journal of Medical Sciences (1 paper)
- Partner nations
- TürkiyeUnited StatesJapan
In The Last Decade
Alpay Azap
63 papers receiving 752 citations
Peers
Comparison fields: 5 of 112
- Applied Microbiology and Biotechnology 88
- Molecular Medicine 109
- Critical Care and Intensive Care Medicine 70
- Infectious Diseases 245
- Obstetrics and Gynecology 78
Countries citing papers authored by Alpay Azap
This map shows the geographic impact of Alpay Azap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpay Azap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpay Azap more than expected).
Fields of papers citing papers by Alpay Azap
This network shows the impact of papers produced by Alpay Azap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpay Azap. The network helps show where Alpay Azap may publish in the future.
Co-authors
The 25 scholars most cited alongside Alpay Azap, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 0 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 27 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 130 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 6 | |
| 15 | 2020 | 0 | |
| 16 | 2019 | 1 | |
| 17 | 'The Lancet' sağlıkta dönüşüm programı’nın ‘başarılarını’ Dünyaya pazarlıyor | 2013 | 1 |
| 18 | 2005 | 0 | |
| 19 | The Antibiotic Usage Before and After a Nationwide Antibiotic Restriction Policy at a University Hospital | 2004 | 0 |
| 20 | 2004 | 51 |
About Alpay Azap
Alpay Azap is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Infectious Diseases, Microbiology and Epidemiology, having authored 76 papers that have together received 779 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (8 papers), Antibiotic Resistance in Bacteria (8 papers), Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Vaccine Coverage and Hesitancy (6 papers), Pneumonia and Respiratory Infections (6 papers) and Influenza Virus Research Studies (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (88 citations), Molecular Medicine (109 citations), Critical Care and Intensive Care Medicine (70 citations), Infectious Diseases (245 citations) and Obstetrics and Gynecology (78 citations). Alpay Azap has collaborated with scholars based in Türkiye, United States and Japan. Frequent co-authors include Önder Ergönül, Erkan Kalafat, Acar Koç, Çağlar Uzun, Fatma Şebnem Erdinç, Ayşe Willke, İrem Akdemir Kalkan, H. Karakayalı, Mehmet Haberal and Hande Arslan. Their work appears in journals such as International Journal of Antimicrobial Agents, American Journal of Infection Control, Infectious Diseases and Therapy, Scientific Reports and International Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.